The incidence of coronary heart disease (CHD) peaks in the elderly population. In secondary and primary prevention trials, cholesterol-lowering therapy reduces risk for CHD in both older and younger participants. This benefit, therefore, can be extended to the elderly.
Grundy SM, Cleeman JI, Rifkind BM, Kuller LH, for the Coordinating Committee of the National Cholesterol Education Program. Cholesterol Lowering in the Elderly Population. Arch Intern Med. 1999;159(15):1670-1678. doi:10.1001/archinte.159.15.1670